Additive Regional Fascial Plain Blocks to Pectointercostal Fascial Block for Postoperative Pain Management After Cardiac Surgery: a Randomized Controlled Trial
Launched by ALEXANDRIA UNIVERSITY · Mar 4, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of pain relief techniques can help reduce postoperative pain for patients undergoing heart surgery. Specifically, researchers are looking at two methods: the Pectointercostal Fascial Block, which helps manage pain after surgery, and an additional technique called the Rectus Sheath Block or External Oblique Intercostal Plane Block, which may provide extra pain relief. This research is important because many patients experience severe pain after heart surgery, particularly in the area where the tube is inserted.
To participate in this trial, you need to be an adult between the ages of 18 and 60 who is scheduled for specific heart surgeries. However, some people may not be eligible, such as those with certain medical conditions, previous surgeries, or those taking chronic pain medications. If you decide to join the study, you’ll receive these pain relief treatments and help researchers understand which method works best for managing pain after heart surgery, ultimately aiming to improve your recovery experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study will include adult patients of both sexes aged 18 to 60 who are scheduled to have fast-tracking elective on-pump cardiac surgery through a median sternotomy with epigastric drain insertion.
- Exclusion Criteria:
- • patients who refused to participate in the study, also
- • who had Cognitive impairment or mental disorders,
- • Ages \<20 and \>65 years,
- • BMI \<18 and \>35,
- • patients with puncture site infection,
- • patients who documented allergy to local anesthetic drugs,
- • patients used to take chronic pain medications,
- • patients who made previous sternotomy or chest surgery and
- • patients with a history of substance abuse.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Islam Elbardan, Dr
Principal Investigator
University of Alexandria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported